Literature DB >> 205507

Role of activated macrophages in resistance of congenitally athymic nude mice to hepatitis induced by herpes simplex virus type 2.

S C Mogensen, H K Andersen.   

Abstract

Congenitally athymic nude (nu/nu) mice of a BALB/c genetic background were found considerably more resistant to the induction of focal necrotic hepatitis by herpes simplex virus type 2 (HSV-2) tha, were phenotypically normal littermates (nu/+) or BALB/c mice. The augmented resistance was age dependent, as it was only manifested in mice from 4 to 5 weeks of age. Studies of the course of infection showed that nude mice were able to restrain virus multiplication in the liver far better than normal mice in the early phase of infection. However, they seemed inferior to normal mice in eliminating the infectious process. In vitro investigation of peritoneal macrophages revealed that macrophages from 6-week-old nude mice exhibited accelerated spreading and were three times as restrictive in the replication of HSV-2 as macrophages from normal mice. However, no difference was found in the efficiency of adsorption/phagocytosis between macrophages from nude and normal mice. The increased resistance of nude mice could be abolished by blockade of the microphage function of the mice by silica. Nude mice reconstituted at birth with thymus cells were just as susceptible to infection as normal mice. These data suggest that the increased resistance of nude mice to HSV-2 hepatitis is due to the presence of nonspecifically activated macrophages before infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 205507      PMCID: PMC422258          DOI: 10.1128/iai.19.3.792-798.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Investigations on the mechanism of stimulation of non-specific immunity by bacterial lipopolysaccharides.

Authors:  J G HOWARD; D ROWLEY; A C WARDLAW
Journal:  Immunology       Date:  1958-07       Impact factor: 7.397

2.  Effect of silica on the pathogenic distinction between herpes simplex virus type 1 and 2 hepatitis in mice.

Authors:  S C Mogensen; H K Andersen
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

3.  Macrophages and age-dependent resistance to hepatitis induced by herpes simplex virus type 2 im mice.

Authors:  S C Mogensen
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

4.  Macrophage activation in congenitally athymic mice raised under conventional or germ-free conditions.

Authors:  G R Rao; W E Rawls; D Y Perey; W A Tompkins
Journal:  J Reticuloendothel Soc       Date:  1977-01

5.  Genetics of macrophage-controlled resistance to hepatitis induced by herpes simplex virus type 2 in mice.

Authors:  S C Mogensen
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

6.  Role of macrophages in hepatitis induced by Herpes simplex virus types 1 and 2 in mice.

Authors:  S Mogensen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

7.  Naturally occurring mouse hepatitis virus infection in the nude mouse.

Authors:  J M Ward; M J Collins; J C Parker
Journal:  Lab Anim Sci       Date:  1977-06

8.  Cell-mediated resistance to infection with Listeria monocytogenes in nude mice.

Authors:  P Emmerling; H Finger; H Hof
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

9.  Biological conditions influencing the focal necrotic hepatitis test for differentiation between herpes simplex virus types 1 and 2.

Authors:  S C Mogensen
Journal:  Acta Pathol Microbiol Scand B       Date:  1976-06

10.  THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE.

Authors:  R T JOHNSON
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Role of macrophages in natural resistance to virus infections.

Authors:  S C Mogensen
Journal:  Microbiol Rev       Date:  1979-03

2.  Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.

Authors:  H J Zweerink; D Martinez; R J Lynch; L W Stanton
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

3.  Resistance of C58 mice to primary systemic herpes simplex virus infection: macrophage dependence and T-cell independence.

Authors:  A J Schlabach; D Martinez; A K Field; A A Tytell
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  [The leukocyte migration inhibition test (LMIT) in recurrent herpes simplex labialis. Comparison of the results of treatment with BCG and Levamisole (author's transl)].

Authors:  R Jarisch; I Sandor; C Cerni
Journal:  Arch Dermatol Res       Date:  1979-05-29       Impact factor: 3.017

5.  Experimental pyelonephritis. The effect of T-cell deficiency on the course of hematogenous enterococcal pyelonephritis in the mouse.

Authors:  H Pitchon; R Glassock; G M Kalmanson; L B Guze
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

6.  Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

Authors:  L K Cauley; J W Murphy
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues.

Authors:  E Hannappel; G J Xu; J Morgan; J Hempstead; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice.

Authors:  J E Oakes; W B Davis; J A Taylor; W A Weppner
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

9.  Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.

Authors:  H S Larsen; R G Russell; B T Rouse
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Protective immunization of mice with specific HSV-1 glycoproteins.

Authors:  W L Chan
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.